Samsung BioLogics implements N-1 perfusion for commercial application

Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device ...

August 13, 2019 | Tuesday | News
AUM Biosciences expands pipeline with new global license agreement

AUM Biosciences (AUM), an award-winning company focused on the development of innovative and affordable oncology medicin...

July 19, 2019 | Friday | News
Wize Pharma enters into JV with Cannabics Pharmaceuticals

Wize Pharma, an Israel based clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, ...

July 1, 2019 | Monday | News
Concept Life Sciences Opens New Pharmaceutical Manufacturing Support Services

Concept Life Sciences, a knowledge-based provider of integrated discovery, development and analytical services, on 18 Ju...

June 28, 2019 | Friday | News
Cobra Biologics, Symbiosis complete £4.8M viral vector supply chain collaboration

Cobra Biologics, an international contract development and manufacturing organisation (CDMO) focused on viral vecto...

June 26, 2019 | Wednesday | News
EMA accepts First "China-Developed" Biosimilar - Henlius HLX02 MAA for Review

Henlius, a leading biotech company in China developing both biosimilar and innovative biologics, on 21 June 20...

June 24, 2019 | Monday | News
WuXi Biologics to expand integrated biologics conjugation solution center

WuXi Biologics ("WuXi Bio"), a leading global open-access biologics technology platform company offering end-to-end solu...

June 21, 2019 | Friday | News
Univercells granted $14.3M to deliver measles and rubella vaccines in LMICs

Univercells, on 13 June 2019, announced that it has been awarded a $14.3M grant by the Bill & Melinda Gates Fou...

June 17, 2019 | Monday | News
CytoDyn, Samsung BioLogics formalize manufacturing partnership

CytoDyn Inc., a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential f...

May 31, 2019 | Friday | News
GeneDesign joins Ajinomoto Bio-pharma

Ajinomoto Bio-Pharma, a leading provider of biopharmaceutical contract development and manufacturing services has a...

April 9, 2019 | Tuesday | News
WuXi Biologics enters into commercial manufacturing partnership with Amicus

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...

February 13, 2019 | Wednesday | News
NextPharma to acquire Santen's Tampere manufacturing facility

Santen SA and NextPharma have announced that Santen’s Tampere manufacturing facility and related operations will b...

January 30, 2019 | Wednesday | News
Merck, Roche to renew global distribution agreement

Merck and Roche have agreed to renew their current distribution agreement for the Biochemical Reagents an...

January 15, 2019 | Tuesday | News
Fujifilm to invest 10B Yen in Bio CDMO biz

FUJIFILM Corporation announced plans to invest approximately JPY 10 billion (approximately $90 million U.S. dollars) in ...

January 8, 2019 | Tuesday | News
Sistema and VTB to create a major pharmaceuticals holding

Sistema PJSFC (“Sistema”), a publicly traded diversified Russian holding company, announces it has acquired ...

December 31, 2018 | Monday | News
Helsinn gives exclusive rights to Menarini for Pracinostat

Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biophar...

December 24, 2018 | Monday | News
Chengdu firms ink pacts for 18 collaborative projects with Thai peers

The highlights of Thailand-Chengdu Cooperation Week 2018, the Economic and Trade Exchange and Business Matching Exchange...

December 19, 2018 | Wednesday | News
Cobra, Pall, Cell and Gene Therapy Catapult win £1.5M Innovate UK grant

Singapore –Cobra Biologics, an international contract development and manufacturing organization (CDMO) ...

November 26, 2018 | Monday | News